Tomczak Szymon, Stawny Maciej, Jelińska Anna
Department of Pharmaceutical Chemistry, Poznan University of Medical Sciences, 6 Grunwaldzka, 60-780 Poznań, Poland.
Pharmaceutics. 2020 Nov 13;12(11):1092. doi: 10.3390/pharmaceutics12111092.
Parenteral nutrition (PN) admixtures are prone to interacting with drugs administered intravenously via a common catheter. This may cause a threat to a patient's health and life. The literature that has been reported on the compatibility of loop diuretics with PN presents conflicting results. This work aimed to study the compatibility of furosemide and torsemide with PN used in clinical practice. Undiluted solutions of drugs were mixed with PN at various ratios determined by flow rates. In order to assess compatibility, visual control was followed by pH measurement, osmolality, mean emulsion droplet diameter (MDD), and zeta potential upon mixing and at 4 h of storage. No macroscopic changes that indicated lipid emulsion degradation were observed. After the addition of the drugs, the value of pH ranged from 6.37 ± 0.01 to 7.38 ± 0.01. The zeta potential was in reverse proportion to the drug concentration. The addition of the drugs did not affect the MDD. It may be suggested that the co-administration of furosemide or torsemide and PN caused no interaction. The absence of such signs of unwanted interactions allowed for the co-administration of the mentioned loop diuretics and PN at each of the studied ratios.
肠外营养(PN)混合液易于与通过同一导管静脉给药的药物发生相互作用。这可能会对患者的健康和生命构成威胁。已报道的关于襻利尿剂与PN相容性的文献结果相互矛盾。这项工作旨在研究临床实践中使用的呋塞米和托拉塞米与PN的相容性。将未稀释的药物溶液以由流速确定的各种比例与PN混合。为了评估相容性,在混合时以及储存4小时后,先进行目视检查,然后测量pH值、渗透压、平均乳滴直径(MDD)和zeta电位。未观察到表明脂质乳剂降解的宏观变化。添加药物后,pH值范围为6.37±0.01至7.38±0.01。zeta电位与药物浓度成反比。添加药物不影响MDD。可以认为,呋塞米或托拉塞米与PN联合给药不会引起相互作用。不存在此类不良相互作用的迹象使得上述襻利尿剂与PN能够以每个研究比例联合给药。